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Terminally protected pentapeptides with 2 histidines (Ac-HHVGD-NH2 and Ac-HVGDH-NH2) and the terminally free peptides
containing both internal aspartyl and C-terminal histidyl residues (FDAH and VIDAH) have been synthesized, and copper(II)
complexes studied by potentiometric, UV-Vis, CD, and EPR spectroscopic techniques in solution. Both thermodynamic and spec-
troscopic data reveal that side chain donor atoms of aspartyl and histidyl residues have a significant contribution to the metal
binding affinity of peptide molecules. In the case of terminally protected peptides, the role of the imidazole-N donor functions is
reflected in the enhanced stability of the 3N and 4N coordinated copper(II) complexes. The amino and β-carboxylate groups of
FDAH and VIDAH create a very effective metal binding site with the (NH2, N
−, β-COO−) and (NH2, N
−, N−, β-COO−) coordi-
nation modes including the N-termini, while the histidine sites are available for the formation of the (Nim, N
−, N−) binding mode
resulting in the preference of dinuclear complex formation.
Copyright © 2007 Csilla Kállay et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Metal complexes of peptides are promising and frequently
used models of the active centres of various metalloenzymes.
The high metal binding affinity of peptide ligands gener-
ally requires the presence of strongly coordinating side chain
residues including the carboxylate and imidazole functions
of aspartyl and histidyl residues, respectively. The metal ion
speciation of these systems and the structural parameters of
the predominating species, however, significantly depend on
the amino acid sequences of the peptides. The most com-
mon features of the coordination chemistry of peptides have
already been reviewed by several authors [1, 2] and the gov-
erning roles of histidyl and aspartyl or glutamyl residues have
also been discussed recently [3, 4]. A great number of stud-
ies revealed the enhanced stability of peptide complexes con-
taining the histidine amino acid close to the terminal amino
groups, for example, the Xaa-His-Xaa-Xaa and Xaa-Xaa-His-
Xaa sequences [3, 4]. In the case of the terminally protected
peptides, the anchoring role of internal histidyl residues has
been well documented and various forms of amide-bonded
complexes have been characterized [5–8]. More recently, the
copper(II) complexes of multihistidine peptides have also
been investigated and the formation of macrochelates sug-
gested [9–11]. The peptide fragments of the hormone thy-
mopoietin served as the simplest models to study the effect of
side chain carboxylate functions on the complex formation
processes of peptides [12, 13]. It was found that the pres-
ence of β-carboxylate functions of aspartyl residues always
results in the enhanced thermodynamic stability of peptide
complexes and in the case of the Xaa-Xaa-Asp-Xaa sequences
the coordination of β-carboxylate-O donor is able to prevent
the deprotonation of subsequent amide functions. A system-
atic study on tetrapeptides containing more aspartyl residues
came to similar conclusions [14]. The metal binding abilities
of the peptides of aspartyl and glutamyl residues were com-
pared recently and the stabilizing role of β-carboxylate func-
tions of aspartyl residues was demonstrated over that of the
γ-carboxylate groups of glutamic acid [15]. The versatility
of the complex formation processes of aspartyl and glutamyl
peptides can be further enhanced by the involvement of the
side chain carboxylates in amide binding. The terminal and
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amide donor functions are separated in these peptides and it
generally results in very complicated solution equilibria in-
cluding the formation of polynuclear species [16, 17]. The
complexity of these systems is best exemplified by the metal
ion interactions of glutathione [18]. On the other hand, only
a few papers have been published on the complex forma-
tion processes of peptides containing both histidyl and as-
partyl residues. The tetrapeptide HisValGlyAsp corresponds
to the 78–81 amino acid fragment of the zinc binding site of
the enzyme CuZn-SOD [19] and its copper(II) and zinc(II)
complexes were studied by potentiometric and spectroscopic
methods both for the free and terminally protected peptides.
The data revealed the governing role of histidyl residue in
the complexation processes with a slight stability enhance-
ment from the aspartyl moiety [20–22]. The active centre
of the enzyme, however, contains more than one histidyl
residues, while the effect of aspartic acid is more pronounced
if it is located in internal position. Now in this paper we
report the synthesis and the results obtained for the cop-
per(II) complexes of four new peptide ligands: (a) the termi-
nally protected pentapeptides including one aspartyl and two
histidyl moieties, Ac-HisHisValGlyAsp-NH2 (Ac-HHVGD-
NH2), Ac-HisValGlyAspHis-NH2 (Ac-HVGDH-NH2), and
(b) the terminally free peptides containing internal aspartyl




The peptides Ac-HisHisValGlyAsp-NH2 (abbreviated as Ac-
HHVGD-NH2), Ac-HisValGlyAspHis-NH2 (Ac-HVGDH-
NH2), PheAspAlaHis (FDAH), and ValIleAspAlaHis (VI-
DAH) were synthesized in the solid state using 2-chlorotrityl
chloride resin and its modified form (H-Linker-CLTR resin).
All solvents and chemicals used for synthesis were from
commercial sources in the highest available purity and
used without further purification. The resins and the pro-
tected amino acids (Fmoc–His(Nim–Mtt)–OH, Fmoc–Val–
OH, Fmoc–Gly–OH, Fmoc-Asp(OtBu)-OH, Fmoc–Phe–
OH, Fmoc–Ala–OH, and Fmoc–Ile–OH were purchased
from CBL Chemical Ltd., (Patras, Greece) and details of the
peptide synthesis have already been described [20].
A stock solution ofcopper(II) chloride was prepared from
analytical grade reagent and the concentration was checked
gravimetrically via the precipitation of oxinate.
2.2. Potentiometric measurements
The pH-potentiometric titrations in the pH range 2.5–11.5
were performed in 3 cm3 samples in the concentration range
2× 10−3–8× 10−3 mol dm−3 at 1 : 2, 1 : 1, and 2 : 1 metal ion
to ligand ratios. The measurements were made with a MOL-
SPIN pH meter equipped with a 6.0234.100 combined elec-
trode (Metrohm) and a MOL-ACS microburette controlled
by computer.
The titrations were performed with carbonate-free stock
solution of potassium hydroxide of known concentration.
During the titration argon was bubbled through the sam-
ples to ensure the absence of oxygen and carbon dioxide and
for stirring of the solutions. All pH-potentiometric measure-
ments were carried out at a constant ionic strength of 0.2 M
KCl and at a constant temperature (298 K). The number of
experimental points reached around 50 to 70 data (cm3-pH)
for each titration curve. The pH readings were converted into
hydrogen ion concentration as described earlier [23]. Proto-
nation constants of the ligands and the overall stability con-
stants (logβpqr) of the complexes were calculated by means
of general computational programs, PSEQUAD [24]and SU-
PERQUAD [25] using (1) as follows







UV-Vis spectra of the copper(II) complexes were recorded
on a Hewlett Packard HP 8453 diode array and on a Perkin-
Elmer Lambda 25 double beam spectrophotometer in the
same concentration range as used for pH-potentiometry.
The EPR continuous wave spectra were recorded at 120 K
in a Varian E109 spectrometer operated at the X-band and
equipped with a cryostat of Oxford Instruments. Experimen-
tal conditions: microwave power 20 mW, modulation am-
plitude 10 G, and sweep width 2000 G. The concentration
of copper(II) and peptides were the same as used for pH-
potentiometry.
CD spectra of copper(II) complexes were recorded on a
JASCO J-81 spectropolarimeter using 1 or 10 mm cells in the
200–800 nm range in the same concentration range as used
for potentiometry. CD spectra of the individual species were
calculated by the same general program (PSEQUAD) as used
for the evaluation of potentiometric measurements.
3. RESULTS AND DISCUSSION
3.1. Protonation constants of the ligands
Protonation macroconstants of the ligands have been deter-
mined by pH-potentiometric measurements and the equilib-
rium data are collected in Table 1.
It is clear from Table 1 that the peptides have 3 or 4 pro-
tonation sites which can be assigned to the terminal amino
and carboxylate groups and the side chain imidazole and
β-carboxylate functions. In agreement with the common
oligopeptides the terminal amino groups are the most ba-
sic sites of the molecules, while the C-terminal α-carboxylic
groups are the most acidic. Taking into account the small dif-
ferences of the stepwise pK values, the unambiguous assign-
ment of the protonation sites would require the determina-
tion of microscopic protonation constants. In the case of the
terminally protected peptides these values have already been
reported [26] and the data revealed the complete overlap in
the basicity of the two imidazole moieties.
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Table 1: Protonation macroconstants and stepwise pK values of the






[HL] 6.91(1) 6.79(1) 7.67(1) 7.84(1)
[H2L] 12.97(1) 12.72(1) 14.56(1) 14.74(1)
[H3L] 16.40(2) 16.34(2) 18.31(1) 18.60(2)
[H4L] — — 21.11(2) 20.95(3)
pK(amino) — — 7.67 7.84
pK(Nim) 6.91 6.79 6.89 6.90
pK(Nim) 6.06 5.93 — —
pK(β-COO−) 3.43 3.62 3.75 3.86
pK(α-COO−) — — 2.80 2.35
Table 2: Stability constants (logβpqr) of the copper(II) complexes









[CuHL] 10.87(4) 10.62(9) 12.95(6) 12.98(2)
[CuL] 6.24(2) 6.42(2) 9.23(1) 7.33(6)
[CuH−1L] −0.24(3) −0.36(4) 3.73(1) 2.20(2)
[CuH−2L] −7.70(3) −7.57(3) −5.77(2) −5.68(5)
[CuH−3L] −18.04(3) −17.03(4) −17.36(2) −17.27(5)
[Cu2L] — — 11.56(8) —
[Cu2H−1L] — — 6.65(7) —
[Cu2H−2L] — — — −0.16(1)
[Cu2H−3L] — — −5.76(3) —
[Cu2H−4L] — — −15.50(5) −12.71(3)
[Cu2H−5L] — — — −23.63(5)
pK(1/0) 4.63 4.20 3.62 5.65
pK(0/−1) 6.48 6.78 5.50 5.13
pK(−1/−2) 7.46 7.21 9.50 7.88
pK(–2/–3) 10.34 9.46 11.59 11.59
log K(Cu + HL) 3.96 3.83 — —
3.2. Copper(II) complexes of the terminally protected
peptides (Ac-HHVGD-NH2 and Ac-HVGDH-NH2)
The stability constants ofthe copper(II) complexes of all pep-
tides were determined by potentiometric measurements and
the data are collected in Table 2. The terminal amino groups
of peptides are the most common anchors for metal bind-
ing and, as a consequence, the complex formation processes
of the terminally free and protected peptides are significantly
different and the results are discussed in separate subsections.
It is clear from Table 2 that the complex formation pro-
cesses of the two terminally protected peptides Ac-HHVGD-
NH2 and Ac-HVGDH-NH2 are very similar to each other




















Figure 1: Metal ion speciation of the copper(II)-Ac-HHVGD-NH2
system at 1 : 1 ratio (cL = 2·10−3 mol/dm3).
tion is shown for the copper(II)-Ac-HHVGD-NH2 system in
Figure 1, but a very similar speciation can be drawn also for
Ac-HVGDH-NH2. Figure 1 clearly demonstrates that com-
plex formation starts in a slightly acidic pH range, above pH
3.5 when only the imidazole functions can be protonated.
Thus, the species [CuHL] and [CuL] can be characterized
by the binding of imidazole-N donor atoms, in the forms
of monodentate imidazole binding (Nim) and macrochelate
(2 × Nim), respectively. The stability constants calculated
for the Cu-Nim binding mode [log K(Cu + HL) values in
Table 2] are slightly higher than those of simple monohis-
tidine peptides [8] suggesting that the β-carboxylate func-
tions of aspartyl residues also have a slight contribution to
metal binding. The data obtained for the macrochelates show
similar tendencies if they are compared to those of the cop-
per(II) complexes of the corresponding bis-histidine pep-
tides [11, 22].
The spectroscopic parameters of the major species are
collected in Table 3 and support the above-mentioned con-
clusions. In the case of the species [CuL] both the absorption
maxima and EPR parameters agree well with those of 2N co-
ordinated complexes in a slightly distorted environment. No
measurable CD spectra can be recorded in these systems be-
low pH 5 and it provides an unambiguous proof for the ex-
clusive binding of imidazole-N donor atoms in the species
[CuHL] and [CuL]. On the other hand, characteristic CD
spectra can be recorded in parallel with the formation of the
[CuH−nL] species supporting that the extra deprotonation
reactions come from the metal ion coordination of the de-
protonated amide functions and mixed hydroxo complexes
are not present in measurable concentration.
The metal binding sites of the ligands in the species
[CuH−nL] can be described by the [Nim,n × N−] coordina-
tion modes (n = 1–3) containing increasing number of amide
nitrogen donor atoms. The pK(n/n−1) values reveal that the
deprotonation of amide functions takes place in consecu-
tive reactions while the cooperative deprotonation of the first
two amide functions was characteristic of many other histi-
dine containing peptides [8]. However, in the case of these
ligands only one of the imidazole residues takes part in the
formation of chelate ring with the amide function and the
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Table 3: Spectroscopic parameters of the major species formed in the copper(II)-Ac-HHVGD-NH2 and Ac-HVGDH-NH2 systems.
Ligand Species Vis (λmax /ε) (nm/dm3mol−1cm−1) EPR (g||/A||) (−/10−4cm−1) CD (λmax /Δε) (nm/dm3mol−1cm−1)
Ac-HHVGD-NH2
[CuHL] 770/55 2.328/153 —













[CuL] 680/64 2.315/155 —
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Scheme 1
other histidine can occupy the free coordination sites cre-
ating a macrochelate structure which stabilizes the species
[CuH−1L]. The spectroscopic data strongly support that the
macrochelate is present in the [CuH−2L] species, too. The
comparison of UV-Vis and EPR parameters in Table 3 with
those of the (Nim, 2 × N−) coordinated complexes of prion
peptide fragments containing only one histidyl residues [8,
27] reveals the increase in the number of coordinated nitro-
gen donors suggesting th(Nim, 2×N−, Nim) binding mode for
the [CuH−2L] species of Ac-HHVGD-NH2 and Ac-HVGDH-
NH2. This coordination mode suppresses the deprotonation
of the third amide functions to a more alkaline pH range












































Figure 2: Metal ion speciation of the copper(II)-FDAH system in (a) equimolar samples and (b) at 2 : 1 metal to ligand ratio (cL =
2·10−3 mol/dm3).
Table 4: Spectroscopic parameters of the major species formed in the copper(II)-FDAH and VIDAH systems.





























(pH > 9) than it was reported for other histidine peptides
(pH < 9). The pK(−2/−3) value is especially high for the lig-
and Ac-HHVGD-NH2, but in this case, starting from the his-
tidyl residues, the amide functions can be deprotonated only
towards the C-terminus in the form of (7,5,5)-membered
fused chelates while they are (6,5,5)-membered ones for the
other ligands. It is also important to note that various co-
ordination isomers of the species [CuH−1L] and [CuH−2L]
can exist because there are several possibilities for the depro-
tonation of the first two amide functions of both ligands. It
is demonstrated by Scheme 1 where the metal binding sites
of the various coordination isomers are indicated by differ-
ent squares and circles. The results of our previous studies
[11] on the copper(II) complexes of multihistidine peptides
revealed that the spectroscopic parameters of these coordina-
tion isomers are very similar to each other. As a consequence,
we cannot estimate the ratio of the various isomers in solu-
tion, but previous studies definitely support that the isomers
built up from 6- and 5-membered chelates predominate over
the 7-membered ones.
In the previous paragraph the equilibrium and spec-
troscopic data reported for the species [CuHL] and [CuL]
































































































revealed the stabilization role of β-carboxylate function in
the Cu–Nim binding mode. On the contrary, the compar-
ison of the recent data obtained for the species [CuH−nL]
with those reported for peptides without additional carboxy-
late functions suggests that β-carboxylate groups of aspartyl
residues do not have a significant contribution to the over-
all stability and structural parameters of amide-bonded com-
plexes.
3.3. Copper(II) complexes of the terminally free
peptides (FDAH and VIDAH)
The metal ion speciation of the copper(II)-FDAH system is
shown in Figure 2 at two different metal ion to ligand ratios.
It is clear from Figure 2 and Table 2 that both mono- and di-
nuclear complexes are formed in this system, thus the peptide
is able to keep more than one equivalent of copper(II) ion in
solution even under alkaline conditions.
The complexation starts in slightly acidic solution below
pH 4 with the formation of the protonated complex [CuHL].
The amino groups are generally the primary ligating sites of
the non-protected peptides [1, 2], thus the amino and neigh-
bouring carbonyl groups are bonded in this species, while the
imidazolium group remains protonated. The concentration
of [CuHL] is, however, very low at any metal ion to ligand ra-
tios and the exact spectral parameters cannot be determined.
The formation of the species [CuL] is accompanied with the
appearance of detectable CD extrema (see Table 4 for spec-
tral parameters) suggesting that formation of [CuL] from
[CuHL] is not simply the deprotonation of the imidazolium
group, but it is the deprotonation of the first amide function
and the real stoichiometry of [CuL] is [Cu(H−1L)H]. The
outstanding stability of the (NH2, N−, β-COO−) coordina-
tion mode has already been reported in several other pep-
tides and the stability constant of such a species is around
2 log units [14]. Correcting the logβ101 value with the pK of
imidazole of FDAH log K = (9.23−6.89 =) 2.34 can be calcu-
lated for [Cu(H−1L)H] supporting the above-mentioned co-
ordination mode. It is also a common feature of the peptides
with Xaa-Asp-Xaa sequences, that the deprotonation of the
second amide functions is significantly suppressed as com-
pared to those of the common oligopeptides. Namely, the
pK(–1/–2) = 9.64 was reported for the tetrapeptide ADAA
[14], which is in a very good agreement with our data in
Table 2. As a consequence, the species [CuH−1L] will pre-
dominate in a wide pH range including the physiological val-
ues. Its stability constant is, however, higher than the char-
acteristic 2 log units, because the deprotonated side chain
imidazole can occupy the fourth coordination site around
the metal ion. This assumption is supported by the slight
blue shift of the absorption maxima upon the formation of
[CuH−1L] from [CuL].
A further base consuming process is detected above pH
9, when both amino and imidazole nitrogen donors are co-
ordinated. The significant blue shift of the absorption max-
ima and characteristic changes of CD spectra unambiguously
prove the coordination of the second amide nitrogens, but
in the forms of various coordination isomers. These isomers
can include the (NH2, N−, N−, Nim) coordination mode
starting from the N-terminus (see Scheme 2(a)) and the
(Nim, N−, N−, (NH2)) coordination mode starting from the
C-terminal histidyl residues (see Scheme 2(b)). The determi-
nation of the exact ratios of the isomers would require the



































































Figure 4: Visible spectra of the copper(II)-VIDAH system in
equimolar samples at different pH values (cL = 2·10−3 mol/dm3).
study of the copper(II) complexes of some model peptides,
but the comparison of the CD spectra of copper(II)-FDAH
with those reported for other histidine peptides [28] suggests
that the metal binding from the histidyl site may predomi-
nate over the amino site in alkaline solutions. It means that
the coordination of the second amide function isnot simply a
deprotonation reaction but it is accompanied with the rear-
rangement of the metal binding sites of the peptides. Namely,
the terminal amino group and the subsequent amide are the
primary ligating sites below pH 9, but they are partly replaced
by the imidazole and preceding amide functions at high pH
values. In agreement with this assumption the deprotonation
of the third amide function (pK(−2/−3) values) is very much
suppressed as compared to that of ADAA (= 9.88).
Figure 2(b) makes it clear that the metal binding of the
histidyl residue is facilitated in the presence of excess metal
ions. The major dinuclear species at 2 : 1 metal ion to ligand
ratios is [Cu2H−3L] which can be easily built up from the su-
perposition of the N-terminal and histidyl binding sites (see























Figure 5: CD spectra of the copper(II)-VIDAH system at 2 : 1 metal
ion to ligand ratios at different pH values (cL = 2·10−3 mol/dm3).
ing in this species and both copper(II) ions have one free co-
ordination site. As a consequence, the formation of mixed
hydroxo complexes is possible by increasing pH, but their
formation is accompanied with very small spectral changes.
The metal ion speciation of the copper(II)-VIDAH sys-
tem is shown in Figure 3 at 1 : 1 and 2 : 1 metal ion to
ligand ratios. The comparison of Figures 2 and 3 reveals a
high similarity in the complex formation processes of FDAH
and VIDAH, but some important differences can also be ob-
served. The stoichiometry of the first species formed below
pH 5 is [CuHL] and taking into account the pH values it can
contain only the imidazole-N atom in protonated from. Its
concentration is, however, significantly higher than its coun-
terpart formed in the copper(II)-FDAH system, suggesting
that the contribution of β-carboxylate group to metal bind-
ing is enhanced with the pentapeptide. The concentration of
[CuL] is negligible and the species [CuH−1L] predominates
in the pH range from 5.5 to 7.5. The coordination mode of
the [CuH−1L] species of N-terminally free peptide complexes
is generally described by the formation of 2N complexes









































(NH2, N−), but the spectroscopic data (see Table 4) contra-
dict with this assumption. Both absorption and CD spec-
tra support the metal binding of 3 nitrogen donor atoms,
that is, the existence of (NH2, N−, N−, β-COO−) coordi-
nation. The outstanding stability of this binding mode has
already been discussed in the introduction and the spectral
parameters in Table 4 are also in good agreement with liter-
ature data [12, 14]. As a consequence, the real stoichiometry
of [CuH−1L] is [Cu(H−2L)H] containing two deprotonated
amide groups, while the imidazolium group remains pro-
tonated. The corresponding pK(–1/–2) value is higher than
that of the free ligand, but similar decrease in the acidity of
non-coordinating side chains has already been reported in
some other peptide complexes containing coordinated amide
functions [29, 30]. The small blue shift of the absorption
spectra (see Figure 4) partly contradicts with the assump-
tion that only the deprotonation of the side chain imida-
zolium group occurs in the pH range 6.5 to 9.5, but the spe-
ciation curves in Figure 3(a) clearly show that formation of
[CuH−2L] significantly overlap with the formation of dinu-
clear species affecting the overall spectra of the samples. At
the first sight it is surprising that the concentration of the
dinuclear complex is more than 30% in equimolar samples,
but the application of the statistical treatment for the dis-
tribution of metal ions among equivalent binding sites re-
sults in a ratio of 25% for dinuclear species [31]. Figure 3(b)
demonstrates that the major dinuclear species [Cu2H−4L]
predominates in a very wide pH range (pH 7–10) and its
exclusive formation is further supported by the CD spectra
depicted at Figure 5.
The metal binding sites of [Cu2H−4L] (see Scheme 4)
can be easily obtained from the superposition of the (NH2,
N−, N−,β-COO−) and (Nim, 2 × N−) coordination modes
starting from the N- and C-termini of the peptide, respec-
tively. This species has only one free coordination site which
is available for hydroxo complex formation in strongly alka-
line samples.
4. CONCLUSIONS
Both thermodynamic and spectroscopic data provide further
evidence that side chain donor atoms of aspartyl and his-
tidyl residues have a significant influence on the metal bind-
ing affinity of peptide molecules. In the case of terminally
protected peptides, like Ac-HHVGD-NH2 and Ac-HVGDH-
NH2 the role of the imidazole-N donor functions are espe-
cially striking resulting in the formation 3N and 4N coor-
dinated copper(II) complexes. The β-carboxylate functions
of aspartic acid is much less pronounced affecting only the
stability constants of the Cu–Nim-bonded species. The pres-
ence of free terminal amino group, however, significantly
changes the complex formation processes. The amino and
β-carboxylate groups of FDAH and VIDAH create a very ef-
fective metal binding site with the (NH2, N−, β-COO−) and
(NH2, N−, N−, β-COO−) coordination modes, respectively,
while the histidine sites are available for the formation of the
(Nim, N−, N−) binding mode. As a consequence, dinuclear
species are formed in high concentration with these peptides,
while the mononuclear species may have a series of coordi-
nation isomers in solution.
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metric and spectroscopic studies on the copper(II) complexes
formed by oligopeptides containing histidine with a protec-
tion at the terminal amino group,” Polyhedron, vol. 20, no. 9-
10, pp. 937–947, 2001.
[6] M. Łuczkowski, H. Kozlowski, M. Stawikowski, et al., “Is the
monomeric prion octapeptide repeat PHGGGWGQ a specific
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[12] I. Sóvágó, T. Kiss, and A. Gergely, “Proton and copper(II)
complexes of the pentapeptide thymopoietin(32−36),” Inorgan-
ica Chimica Acta, vol. 93, no. 4, pp. L53–L55, 1984.
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[24] L. Zékány and I. Nagypál, “Computational Methods for
the Determination of Formation Constants,” in Computa-
tional Methods for the Determination of Stability Constants, D.
Leggett, Ed., pp. 291–299, Plenum Press, New York, NY, USA,
1985.
[25] P. Gans, A. Sabatini, and A. Vacca, “SUPERQUAD: an im-
proved general program for computation of formation con-
stants from potentiometric data,” Journal of the Chemical So-
ciety, Dalton Transactions, no. 6, pp. 1195–1200, 1985.
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